REG - Applied Nutrition - Trading Update

Applied NutritionAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251209:nRSI7156Ka&default-theme=true

RNS Number : 7156K  Applied Nutrition PLC  09 December 2025

9 December 2025

 Applied Nutrition plc

 

(the "Company")

Trading Update

 

Applied Nutrition plc (LSE: APN), a leading sports nutrition, health and
wellness brand, today announces an update on trading for the current financial
year ending 31 July 2026 ("FY26").

 

Further to the Company's positive trading outlook mentioned in the Final
Results announcement on 10 November 2025, Applied Nutrition is pleased to
announce that the strong momentum has continued and is also reflected in the
current order book.

 

As a result the Company now expects that FY26 results are likely to exceed
current market consensus estimates(1) by approximately 10%.

 

The Company recognises the strength of trading and the upcoming peak trading
period for Health, Fitness & Wellbeing, which will deliver a particularly
strong H1.

 

 

(1 )Consensus market expectations for FY26 before today were revenue of
£122.3m and adjusted EBITDA of £34.4m.

For further information please contact:

 Applied Nutrition plc                                                         Via Alma

 Thomas Ryder, Chief Executive Officer

Steven Granite, Chief Operating Officer

Joe Pollard, Chief Financial Officer
 Alma Strategic Communications (Public Relations adviser to Applied Nutrition  +44 (0) 203 405 0205
 plc)

                                                                             appliednutrition@almastrategic.com
 Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation.  The person responsible for arranging the
release of this announcement on behalf of Applied Nutrition is Joe Pollard,
Chief Financial Officer.

Notes to editors

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and
wellness brand, which formulates and creates nutrition products with a stated
aim of being the world's most trusted and innovative brand in the market.

Headquartered in the UK, the Group sells products in over 85 countries
worldwide and has a diverse product range, targeting elite athletes, gym goers
and health-conscious consumers. Applied Nutrition has developed and launched
four ranges under the umbrella of the Applied Nutrition brand - Applied
Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group
sells over 100 different products.

Applied Nutrition's growth is fuelled by a market-leading product portfolio,
created and largely manufactured in-house at its Knowsley, Liverpool
headquarters by a team of industry experts. This end-to-end capability allows
the Group to innovate at speed, refresh and enhance existing products and
introduce new offerings that anticipate and respond to the latest consumer
trends.

Applied Nutrition largely operates a global business-to-business (B2B) model,
which has facilitated a low risk, highly cost-effective go-to-market strategy
and has enabled strong, profitable growth in the UK, Europe and other
international geographies. The business model and strategy has enabled the
Group to become a fast-growing, highly profitable and cash generative global
supplier in the sports nutrition, health and wellness market.

For further information, please visit www.appliednutritionplc.com
(http://www.appliednutritionplc.com/)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUWRBRVVUURAA



            Copyright 2019 Regulatory News Service, all rights reserved